These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 23706691)
21. Inactivation of prosurvival Bcl-2 proteins activates Bax/Bak through the outer mitochondrial membrane. O'Neill KL; Huang K; Zhang J; Chen Y; Luo X Genes Dev; 2016 Apr; 30(8):973-88. PubMed ID: 27056669 [TBL] [Abstract][Full Text] [Related]
22. The proteasome inhibitor MG132 potentiates TRAIL receptor agonist-induced apoptosis by stabilizing tBid and Bik in human head and neck squamous cell carcinoma cells. Sung ES; Park KJ; Choi HJ; Kim CH; Kim YS Exp Cell Res; 2012 Aug; 318(13):1564-76. PubMed ID: 22513214 [TBL] [Abstract][Full Text] [Related]
23. Contribution of BH3-domain and Transmembrane-domain to the Activity and Interaction of the Pore-forming Bcl-2 Proteins Bok, Bak, and Bax. Stehle D; Grimm M; Einsele-Scholz S; Ladwig F; Johänning J; Fischer G; Gillissen B; Schulze-Osthoff K; Essmann F Sci Rep; 2018 Aug; 8(1):12434. PubMed ID: 30127460 [TBL] [Abstract][Full Text] [Related]
24. Deficient activation of Bak and Bax confers resistance to gemtuzumab ozogamicin-induced apoptotic cell death in AML. Haag P; Viktorsson K; Lindberg ML; Kanter L; Lewensohn R; Stenke L Exp Hematol; 2009 Jun; 37(6):755-66. PubMed ID: 19463775 [TBL] [Abstract][Full Text] [Related]
25. Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies. Kim H; Rafiuddin-Shah M; Tu HC; Jeffers JR; Zambetti GP; Hsieh JJ; Cheng EH Nat Cell Biol; 2006 Dec; 8(12):1348-58. PubMed ID: 17115033 [TBL] [Abstract][Full Text] [Related]
26. An antiapoptotic Bcl-2 family protein index predicts the response of leukaemic cells to the pan-Bcl-2 inhibitor S1. Zhang Z; Liu Y; Song T; Xue Z; Shen X; Liang F; Zhao Y; Li Z; Sheng H Br J Cancer; 2013 May; 108(9):1870-8. PubMed ID: 23558901 [TBL] [Abstract][Full Text] [Related]
27. Bok is a genuine multi-BH-domain protein that triggers apoptosis in the absence of Bax and Bak. Einsele-Scholz S; Malmsheimer S; Bertram K; Stehle D; Johänning J; Manz M; Daniel PT; Gillissen BF; Schulze-Osthoff K; Essmann F J Cell Sci; 2016 Jun; 129(11):2213-23. PubMed ID: 27076518 [TBL] [Abstract][Full Text] [Related]
28. NBK/BIK antagonizes MCL-1 and BCL-XL and activates BAK-mediated apoptosis in response to protein synthesis inhibition. Shimazu T; Degenhardt K; Nur-E-Kamal A; Zhang J; Yoshida T; Zhang Y; Mathew R; White E; Inouye M Genes Dev; 2007 Apr; 21(8):929-41. PubMed ID: 17403773 [TBL] [Abstract][Full Text] [Related]
29. Expression and Relationship of SAMHD1 with Other Apoptotic and Autophagic Genes in Acute Myeloid Leukemia Patients. Jiang H; Li C; Liu Z; Shengjing Hospital ; Acta Haematol; 2020; 143(1):51-59. PubMed ID: 31434075 [TBL] [Abstract][Full Text] [Related]
30. Characterization of the anti-apoptotic mechanism of Bcl-B. Zhai D; Ke N; Zhang H; Ladror U; Joseph M; Eichinger A; Godzik A; Ng SC; Reed JC Biochem J; 2003 Nov; 376(Pt 1):229-36. PubMed ID: 12921534 [TBL] [Abstract][Full Text] [Related]
31. Superior anti-tumor activity of the MDM2 antagonist idasanutlin and the Bcl-2 inhibitor venetoclax in p53 wild-type acute myeloid leukemia models. Lehmann C; Friess T; Birzele F; Kiialainen A; Dangl M J Hematol Oncol; 2016 Jun; 9(1):50. PubMed ID: 27353420 [TBL] [Abstract][Full Text] [Related]
32. Maximal Activation of Apoptosis Signaling by Cotargeting Antiapoptotic Proteins in BH3 Mimetic-Resistant AML and AML Stem Cells. Carter BZ; Mak PY; Tao W; Zhang Q; Ruvolo V; Kuruvilla VM; Wang X; Mak DH; Battula VL; Konopleva M; Jabbour EJ; Hughes PE; Chen X; Morrow PK; Andreeff M Mol Cancer Ther; 2022 Jun; 21(6):879-889. PubMed ID: 35364607 [TBL] [Abstract][Full Text] [Related]
33. Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Willis SN; Fletcher JI; Kaufmann T; van Delft MF; Chen L; Czabotar PE; Ierino H; Lee EF; Fairlie WD; Bouillet P; Strasser A; Kluck RM; Adams JM; Huang DC Science; 2007 Feb; 315(5813):856-9. PubMed ID: 17289999 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of autophagy as a treatment strategy for p53 wild-type acute myeloid leukemia. Folkerts H; Hilgendorf S; Wierenga ATJ; Jaques J; Mulder AB; Coffer PJ; Schuringa JJ; Vellenga E Cell Death Dis; 2017 Jul; 8(7):e2927. PubMed ID: 28703806 [TBL] [Abstract][Full Text] [Related]
35. AICAR induces Bax/Bak-dependent apoptosis through upregulation of the BH3-only proteins Bim and Noxa in mouse embryonic fibroblasts. González-Gironès DM; Moncunill-Massaguer C; Iglesias-Serret D; Cosialls AM; Pérez-Perarnau A; Palmeri CM; Rubio-Patiño C; Villunger A; Pons G; Gil J Apoptosis; 2013 Aug; 18(8):1008-16. PubMed ID: 23605481 [TBL] [Abstract][Full Text] [Related]
36. Bim plays a crucial role in synergistic induction of apoptosis by the histone deacetylase inhibitor SBHA and TRAIL in melanoma cells. Gillespie S; Borrow J; Zhang XD; Hersey P Apoptosis; 2006 Dec; 11(12):2251-65. PubMed ID: 17051334 [TBL] [Abstract][Full Text] [Related]
37. Induction of apoptosis in prostate carcinoma cells by BH3 peptides which inhibit Bak/Bcl-2 interactions. Finnegan NM; Curtin JF; Prevost G; Morgan B; Cotter TG Br J Cancer; 2001 Jul; 85(1):115-21. PubMed ID: 11437412 [TBL] [Abstract][Full Text] [Related]
38. Constitutive BAK activation as a determinant of drug sensitivity in malignant lymphohematopoietic cells. Dai H; Ding H; Meng XW; Peterson KL; Schneider PA; Karp JE; Kaufmann SH Genes Dev; 2015 Oct; 29(20):2140-52. PubMed ID: 26494789 [TBL] [Abstract][Full Text] [Related]
39. Induction of p53 contributes to apoptosis of HCT-116 human colon cancer cells induced by the dietary compound fisetin. Lim DY; Park JH Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1060-8. PubMed ID: 19264955 [TBL] [Abstract][Full Text] [Related]
40. BH3-mimetics- and cisplatin-induced cell death proceeds through different pathways depending on the availability of death-related cellular components. Andreu-Fernández V; Genovés A; Messeguer A; Orzáez M; Sancho M; Pérez-Payá E PLoS One; 2013; 8(2):e56881. PubMed ID: 23437261 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]